California lawmakers to vote on $308B spending plan
California lawmakers will vote on a plan to spend nearly $308 billion in taxpayer dollars over the next year. A chunk will go towards providing inflation relief.
FDA authorizes COVID-19 vaccines for kids under 5
The Food and Drug Administration for the first time authorized the coronavirus vaccine for children five years of age and younger.
Best, worst states for working dads in 2022: Report
To find the best and worst states for working dads this year, WalletHub compared all 50 U.S. states, as well as Washington, D.C., based on 23 metrics.
Baby formula shortage: White House to ship more than 44,000 pounds
The White House announced a seventh mission for its "Operation Fly Formula," sending more than 44,000 pounds of infant formula from Switzerland to Kentucky.
FDA investigated more baby deaths related to Abbott plant than previously known: report
The Food and Drug Administration reportedly investigated more child deaths due to contaminated baby formula from Michigan's Abbott plant than previously known.
COVID vaccines: FDA to meet over Novavax
A Food and Drug Administration (FDA) advisory committee is meeting on Tuesday to discuss a request for emergency use authorization (EUA) for Novavax COVID vaccines.
Consumer Reports reveals top sunscreens of 2022
Consumer Reports tested spray and lotion sunscreens based on their SPF and UVA protection.
Monkeypox isn’t ‘same kind of virus’ as COVID, doctor says
Northwell Health Internist Dr. Frank Contacessa said there is no asymptomatic spread with monkeypox unless you are close to someone "exhibiting symptoms."
Monkeypox vaccine will be released from US stockpile, CDC says
Monkeypox virus vaccines are being released to counter cases in the U.S. Symptoms of monkeypox include fever and aches.
Baby formula flights to relieve shortage to arrive this weekend
The first military aircraft carrying pallets of baby formula will arrive in the U.S. this weekend. The February closure of an Abbott Nutrition plant has led to a nationwide shortage.
'Pharma bro' Martin Shkreli released from prison early to halfway house
Martin Shkreli was released from federal prison into a halfway house on Wednesday, the Bureau of Prisons confirmed to FOX Business.
Free COVID tests: How to order
The Biden administration announced the third distribution of free at-home COVID tests for U.S. residents this week. The government website is accepting orders.
FDA authorizes Pfizer booster shots for kids ages 5-11
The U.S. Food and Drug Administration (FDA) amended the emergency use authorization for Pfizer-BioNTech COVID-19 vaccine. The agency is allowing the use of a single booster dose in kids ages 5 to 11.
Health care costs for retired Americans expected to surge next year
The average 65-year-old couple retiring this year can expect to spend an average of $315,000 in health care and other related medical expenses during their retirement, according to Fidelity.
The best, worst states for nurses in 2022: report
As we celebrate National Nurses Week, WalletHub found the best and worst states for nurses.
Moderna's first-quarter profit triples on vaccine sales
Moderna said Wednesday that revenue from its COVID-19 vaccine sales helped the company to triple its net income in a better-than-expected first quarter.
Moderna asks FDA to authorize COVID vaccine for emergency use in children under 6
Moderna asked Food and Drug Administration (FDA) regulators on Thursday to authorize its COVID-19 vaccine for emergency use in children under 6 years of age.
House committee questions McKinsey executive over opioid, FDA consulting work
Members of Congress questioned global consulting firm McKinsey & Company's top managing partner Wednesday about the company's work for U.S. health regulators as it advised opioid drugmakers on how to boost painkiller sales. The hearing is part of an ongoing investigation into McKinsey's role in the opioid crisis.
US FDA approves Gilead's COVID-19 drug for young children
The FDA has granted full approval to Gilead's remdesivir COVID-19 treatment for children 28 days and older.
Pfizer recalls some batches of blood pressure drug over carcinogen presence
Pfiizer announced Friday it was recalling five batches of its Accuprril blood pressure tablets due to cancer-causing agent presence.